AI Model Identifies Diabetic Patients at High Risk for Heart Failure
The AI tool detects a specific high-risk group of diabetic patients with abnormal heart function, which raises their risk of heart failure.
The AI tool detects a specific high-risk group of diabetic patients with abnormal heart function, which raises their risk of heart failure.
A new study finds that generative AI can rapidly and accurately screen patients for clinical trial eligibility based on their medical records.
The AI-enhanced digital stethoscope enables healthcare providers to detect low ejection fraction, a key indicator of heart failure, within 15 seconds during a standard physical exam.
Read MoreThe model better predicts 10-year risk for major adverse cardiovascular events beyond the current clinical risk score, even for patients whose score cannot be calculated due to missing data, a new study finds.
Read MoreThe AI module enables fully automated segmentation of CT images in the creation of 3D cardiac models, allowing inHEART to deliver its solution to physicians with greater speed and efficiency.
Read MoreThe investigators say their AI measurement tool offers new help in predicting heart attacks and cardiovascular disease.
Read MoreUsing the results of a standard blood test and an online tool, you can find out if you are at increased risk of having a heart attack within six months.
Read MoreWhile a mechanical heart pump can be a lifesaving intervention for patients with late-stage failure of the left side of the heart, the surgery to implant the pump can be risky. A new calculator helps tailor the risk assessment for each patient.
Read MoreDistributing these devices could allow healthcare workers, without specialized medical degrees, to carry technology that could detect rheumatic heart disease in regions where it remains endemic, according to the researchers.
Read MoreThe US Food and Drug Administration has granted FDA 510(k) clearance to Nanowear’s SimpleSense, an artificial intelligence-enabled non-invasive, cuffless continuous blood pressure monitor and diagnostic.
Read MoreThe FDA has granted Breakthrough Device designation to CLAiR, an AI-driven platform that uses images from routine eye exams to non-invasively assess and predict cardiovascular disease risk.
Read More